Clinical Trials
2 trialsNCT02016872 2025-04-30
Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01213030 2012-09-25
Clinical Evaluation of the New Hypoxia Imaging Agent HX4
Siemens Molecular Imaging
Phase 1/2 Completed